Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases

Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases

US Patent 8569347 · Granted Oct 29, 2013

Estimated economic value: $398,464,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Folate receptor targeted nanoparticle drug conjugates and uses thereof2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2023
Tricyclic compounds as anticancer agents2018
Tricyclic compounds as anticancer agents2017
Combination therapy for the treatment of proliferative diseases2016
Tricyclic compounds as anticancer agents2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof2015
Use of epothilone D in treating Tau-associated diseases including Alzheimer's di2014
Bisfluoroalkyl-1,4-benzodiazepinone compounds2014
Combination of epothilone analogs and chemotherapeutic agents for the treatment 2013
Methods of identifying and treating individuals exhibiting mutant kit protein2012